Cargando…
Are patients with systemic lupus erythematosus at increased risk for COVID-19? A bi-directional Mendelian randomisation study
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412039/ https://www.ncbi.nlm.nih.gov/pubmed/36002180 http://dx.doi.org/10.1136/lupus-2022-000786 |
| _version_ | 1784775401599401984 |
|---|---|
| author | Ran, Shu Pan, Lixin Liu, Baolin |
| author_facet | Ran, Shu Pan, Lixin Liu, Baolin |
| author_sort | Ran, Shu |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9412039 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | BMJ Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94120392022-08-26 Are patients with systemic lupus erythematosus at increased risk for COVID-19? A bi-directional Mendelian randomisation study Ran, Shu Pan, Lixin Liu, Baolin Lupus Sci Med Letter BMJ Publishing Group 2022-08-24 /pmc/articles/PMC9412039/ /pubmed/36002180 http://dx.doi.org/10.1136/lupus-2022-000786 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
| spellingShingle | Letter Ran, Shu Pan, Lixin Liu, Baolin Are patients with systemic lupus erythematosus at increased risk for COVID-19? A bi-directional Mendelian randomisation study |
| title | Are patients with systemic lupus erythematosus at increased risk for COVID-19? A bi-directional Mendelian randomisation study |
| title_full | Are patients with systemic lupus erythematosus at increased risk for COVID-19? A bi-directional Mendelian randomisation study |
| title_fullStr | Are patients with systemic lupus erythematosus at increased risk for COVID-19? A bi-directional Mendelian randomisation study |
| title_full_unstemmed | Are patients with systemic lupus erythematosus at increased risk for COVID-19? A bi-directional Mendelian randomisation study |
| title_short | Are patients with systemic lupus erythematosus at increased risk for COVID-19? A bi-directional Mendelian randomisation study |
| title_sort | are patients with systemic lupus erythematosus at increased risk for covid-19? a bi-directional mendelian randomisation study |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412039/ https://www.ncbi.nlm.nih.gov/pubmed/36002180 http://dx.doi.org/10.1136/lupus-2022-000786 |
| work_keys_str_mv | AT ranshu arepatientswithsystemiclupuserythematosusatincreasedriskforcovid19abidirectionalmendelianrandomisationstudy AT panlixin arepatientswithsystemiclupuserythematosusatincreasedriskforcovid19abidirectionalmendelianrandomisationstudy AT liubaolin arepatientswithsystemiclupuserythematosusatincreasedriskforcovid19abidirectionalmendelianrandomisationstudy |